logo
Sign in

OBLN Stock Price, Chart, Stats & News

Obalon Therapeutics, Inc.
Save
5.47M
Market cap
Current P/E
Forward P/E

OBLN chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
68.43%
Operating margin
-3237.78%
Pretax margin
-3277.21%
Net margin
-2897.28%
Effective tax rate
-0.21%
ROA
-142.57%
ROE
-277.53%
D/E
0.01x
Interest coverage ratio
-61.39x

OBLN valuation

P/E
P/S
17.12x
P/B
0.95x
P/CF
-0.44x
P/FCF
-0.68x
P/OCF
-0.44x
PEG
-0.00x
EV multiple
-1.01x

About

Obalon Therapeutics, Inc. operates as a fully integrated medical device enterprise, concentrating its efforts on creating and commercializing innovative solutions for individuals battling obesity. The company's flagship offering is the Obalon Balloon System, specifically engineered to promote weight reduction in obese patients. This comprehensive system incorporates an ingestible capsule that houses an inflatable balloon connected to a microcatheter.

Similar securities

Based on sector and market capitalization

Report issue